Biomarkers of Physiological Stress During Prolonged Hospital Stay

Abstract

Physiological stress is a critical concern among patients experiencing prolonged hospital stays, often leading to adverse outcomes such as delayed recovery, increased morbidity, and higher healthcare costs. This review synthesizes current evidence on biomarkers that objectively quantify physiological stress, elucidates their underlying mechanisms, and discusses their clinical relevance in the context of hospital-based care. By evaluating both traditional and emerging biomarkers—such as cortisol, C-reactive protein, interleukin-6, and novel molecular indicators—this article provides a comprehensive overview for clinicians seeking to optimize patient monitoring, risk stratification, and targeted interventions during extended hospitalization.

Introduction

Prolonged hospitalization, defined as an inpatient stay exceeding expected duration for a given diagnosis, is associated with increased all-cause morbidity and mortality. Physiological stress, resulting from factors such as immobility, nosocomial infections, and psychological distress, is a significant contributor to these poor outcomes. Identifying reliable biomarkers of stress is essential for early detection, monitoring, and intervention, thereby improving clinical trajectories and resource utilization. Recent advances in biomarker research have enabled a more nuanced understanding of stress-related pathophysiology in hospitalized patients, offering new avenues for precision medicine.

Epidemiology / Disease Burden

Globally, millions of patients experience extended hospitalizations annually, particularly in intensive care, surgical, and geriatric units. Epidemiological studies demonstrate that up to 20% of inpatients undergo stays exceeding two weeks, with a substantial proportion developing complications directly related to physiological stress. These complications include muscle wasting, metabolic derangements, immunosuppression, and delirium. The financial and societal burden is considerable, highlighting the need for effective monitoring and mitigation strategies focused on stress biomarkers.

Pathophysiology

Physiological stress during prolonged hospitalization activates the hypothalamic-pituitary-adrenal (HPA) axis, resulting in elevated cortisol production. Concomitantly, the sympathetic nervous system is stimulated, increasing catecholamine release and altering cardiovascular dynamics. Persistent inflammatory signaling, typified by upregulation of cytokines such as IL-6 and TNF-α, further exacerbates tissue damage and impairs healing. Oxidative stress markers, including malondialdehyde and 8-isoprostane, indicate cellular injury due to reactive oxygen species. These interconnected pathways collectively fuel the cycle of stress-induced morbidity in hospitalized patients.

Risk Factors

Several risk factors predispose patients to heightened physiological stress during prolonged hospital stays. Advanced age, comorbidities (such as diabetes, chronic kidney disease, or heart failure), polypharmacy, and pre-existing malnutrition increase vulnerability. Surgical interventions, mechanical ventilation, immobilization, and frequent invasive procedures further amplify stress responses. Psychological factors, including anxiety and depression, synergize with physical stressors, underscoring the importance of holistic patient assessment.

Clinical Features

Patients exhibiting significant physiological stress may present with fluctuating vital signs, persistent tachycardia, hypertension, hyperglycemia, and impaired wound healing. Neurological features, such as delirium or cognitive decline, are common, especially among elderly patients. Laboratory abnormalities often include leukocytosis, elevated inflammatory markers, and dysregulated endocrine profiles. The clinical spectrum is broad, necessitating the use of objective biomarkers for accurate and timely assessment.

Diagnosis

Diagnosis of physiological stress relies on a combination of clinical assessment and laboratory evaluation. Cortisol levels, both in serum and salivary samples, are established markers of HPA axis activation. Inflammatory biomarkers such as C-reactive protein (CRP), interleukin-6 (IL-6), and procalcitonin are routinely measured to gauge systemic inflammatory response. Additional markers, including heart rate variability (HRV) for autonomic function and oxidative stress indicators, offer supplementary information. Serial measurements enhance diagnostic accuracy and facilitate dynamic risk stratification during hospitalization.

Treatment & Management

Management of physiological stress involves both general and targeted interventions. Early mobilization, adequate nutrition, and pain control are foundational strategies. Pharmacological approaches may include corticosteroid modulation in select cases, but require caution due to potential adverse effects. Psychological support, environmental modifications, and reduction of unnecessary interventions also play critical roles in minimizing stress. Biomarker-guided management protocols are emerging as effective tools for individualized care planning and outcome optimization.

Recent Advances / Emerging Therapies

Recent research has identified novel biomarkers such as copeptin, chromogranin A, and microRNAs that may offer superior sensitivity and specificity in detecting physiological stress. Multiplex assays and machine learning algorithms are being applied to integrate multi-biomarker panels for more accurate prognostication. Investigational therapies targeting cytokine modulation, oxidative stress reduction, and neuroendocrine stabilization are under clinical evaluation, with early data suggesting potential benefit in reducing stress-related complications during prolonged hospital stays.

Guideline Recommendations

Current clinical guidelines from major organizations, including the Society of Critical Care Medicine (SCCM) and the European Society of Intensive Care Medicine (ESICM), recommend routine assessment of stress biomarkers in high-risk hospitalized patients. Multidisciplinary approaches, early intervention, and individualized monitoring are emphasized. Guidelines advocate for the integration of biomarker data with clinical judgment to inform decision-making and resource allocation. Periodic re-evaluation of biomarker utility is encouraged in light of evolving evidence.

Conclusion

Biomarkers of physiological stress are invaluable tools in the management of patients undergoing prolonged hospital stays. They enable objective monitoring, facilitate early identification of complications, and support tailored therapeutic strategies. Ongoing research continues to expand the repertoire of available biomarkers and clarify their roles in clinical practice. Incorporation of these biomarkers into guideline-based care pathways holds promise for improving patient outcomes and reducing the burden associated with extended hospitalization.